Touted as the largest pharmaceutical sector merger in Africa, the 2024 acquisition of Kelix Bio by Mubadala Investment Co, Abu Dhabi’s sovereign wealth fund, is causing a stir in financial circles in both Casablanca and in the Emirates. The case, initiated following […]
Touted as the largest pharmaceutical sector merger in Africa, the 2024 acquisition of Kelix Bio by Mubadala Investment Co, Abu Dhabi’s sovereign wealth fund, is causing a stir in financial circles in both Casablanca and in the Emirates. The case, initiated following […] Read More